Askbio

AskBio Inc. is a biotechnology company specializing in the research, development, and manufacturing of gene therapies for a range of genetic diseases, with a particular focus on neuromuscular, central nervous system, and cardiovascular disorders. The company generates revenue by licensing its proprietary adeno-associated virus (AAV) gene delivery technology and advancing its own therapeutic pipeline, often through partnerships and collaborations with larger pharmaceutical firms. Founded in 2001 by Dr. Jude Samulski, a pioneer in AAV gene therapy, AskBio has played a significant role in advancing the field and was acquired by Bayer AG in 2020, which has enabled further expansion of its capabilities and resources. Candidates should be aware of AskBio’s commitment to innovation, its collaborative culture, and its mission to develop transformative therapies for patients with unmet medical needs.

Recent Posts by Askbio

1-8 of 8